EUVIMEDEUVIMED entdecken
Open Access

Flecainide sensitizes conduction to hyponatremia through an ephaptic mechanism

William P Adams, Gregory S Hoeker, Steven Poelzing

Heart Rhythm · 2026-04 · 23 (4) · 974-984

DOI: 10.1016/j.hrthm.2025.04.048 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Heart Rhythm, 2026-04. Verfasst von William P Adams und 2 weiteren Autor:innen. Beteiligte Einrichtung: Translational Biology, Medicine, and Health Graduate Program, Virginia Polytechnic Institute and State University, Roanoke, Virginia; Fralin Biomedic…. Hauptthemen laut MEDLINE: Flecainide, Heart Conduction System, Hyponatremia. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHLBI NIH HHS, National Heart Lung and Blood Institute Division of Intramural Research, National Heart, Lung, and Blood Institute.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Studies suggest that voltage-gated sodium channel (SC) loss-of-function (LoF), often through the use of SC blockers, such as tricyclic anti-depressants, some recreational drugs, and importantly, class 1c anti-arrhythmics, sensitizes cardiac conduction to hyponatremia. However, the mechanism driving conduction velocity (CV) sensitivity to sodium ion (Na+) concentration ([Na+]) is unknown. We recently demonstrated CV-[Na+] sensitivity in haploinsufficient Scn5a+/- mouse and reduced CV-[Na+] sensitivity when ephaptic coupling (extracellular conduction by electric fields) is also reduced. OBJECTIVE: We aimed to determine which mechanisms influence CV sensitivity to [Na+] during voltage-gated SC LoF induced by the class 1c anti-arrhythmic, flecainide. METHODS: CV was measured by optical mapping of Langendorff-perfused guinea pig hearts with either 145 or 120 mM [Na+] under control conditions, with flecainide alone, and the combination of flecainide with ephaptic coupling uncouplers mannitol or peptide sequence Leu-Gln-Leu-Glu-Glu-Asp, Na+-calcium ion exchanger inhibitor SEA0400, Na+-potassium ion (K+) adenosine triphosphatase inhibitor ouabain, IKr blocker E4031, or IK1 inhibitor barium chloride. CV-[Na+] sensitivity was quantified as percent CV slowing in response to lowering Na+. RESULTS: Reducing [Na+] under control conditions did not slow CV. Reducing [Na+] in the presence of flecainide significantly slowed conduction (ie, [Na+] sensitivity). Both ephaptic coupling uncouplers significantly attenuated CV-[Na+] sensitivity. Inhibiting the Na+-calcium ion exchanger did not significantly change CV-[Na+] sensitivity. However, inhibiting outward K+ currents attenuated CV-[Na+] sensitivity. CONCLUSION: SC LoF sensitizes conduction to changes in Na+ through ephaptic coupling and outward K+ current-mediated mechanisms. This study has implications for the management of plasma Na+ levels in patients on SC-blocking drugs.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

FlecainideHeart Conduction SystemHyponatremiaAnimalsGuinea PigsDisease Models, AnimalAnti-Arrhythmia AgentsAction PotentialsMaleSodium

Stichwörter der Autor:innen

ConductionElectrophysiologyEphaptic couplingFlecainide toxicityHyponatremiaOptical mapping

Substanzen

FlecainideAnti-Arrhythmia AgentsSodium

Autor:innen und Institutionen

  • Translational Biology, Medicine, and Health Graduate Program, Virginia Polytechnic Institute and State University, Roanoke, Virginia; Fralin Biomedical Research Institute at Virginia Tech Carilion, Center for Vascular a…
  • Fralin Biomedical Research Institute at Virginia Tech Carilion, Center for Vascular and Heart Research, Roanoke, Virginia.
  • Fralin Biomedical Research Institute at Virginia Tech Carilion, Center for Vascular and Heart Research, Roanoke, Virginia; Department of Biomedical Engineering and Mechanics, Virginia Polytechnic Institute and State Uni…

Förderung

  • NHLBI NIH HHS
  • National Heart Lung and Blood Institute Division of Intramural Research
  • National Heart, Lung, and Blood Institute

Zitieren

APA

Adams, W. P., Hoeker, G. S., & Poelzing, S. (2026). Flecainide sensitizes conduction to hyponatremia through an ephaptic mechanism. Heart Rhythm, 23(4), 974-984. https://doi.org/10.1016/j.hrthm.2025.04.048

Vancouver

Adams WP, Hoeker GS, Poelzing S. Flecainide sensitizes conduction to hyponatremia through an ephaptic mechanism. Heart Rhythm. 2026;23(4):974-984. doi:10.1016/j.hrthm.2025.04.048

BibTeX
@article{Adams2026,
  author = {Adams, William P and Hoeker, Gregory S and Poelzing, Steven},
  title = {Flecainide sensitizes conduction to hyponatremia through an ephaptic mechanism},
  journal = {Heart Rhythm},
  year = {2026},
  volume = {23},
  number = {4},
  pages = {974--984},
  doi = {10.1016/j.hrthm.2025.04.048}
}
Kostenlos starten →